OVERVIEW
The Global Stem Cell Manufacturing Market is expected to hit USD 16.05 billion by 2025, rising by 5.6% to CAGR during the forecast period. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics are driving demand for Global Stem Cell Manufacturing Market.
TABLE OF CONTENT
1 Global Stem Cell Manufacturing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Stem Cell Manufacturing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Stem Cell Manufacturing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Stem Cell Manufacturing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Stem Cell Manufacturing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Stem Cell Manufacturing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Stem Cell Manufacturing Market – By Product (Market Size – & million/billion)
8.1 Stem Cell Lines
8.2 Instruments
8.3 Culture Media
8.4 Consumables
9 Global Stem Cell Manufacturing Market – By Application
9.1 Research Applications
9.2 Clinical Applications
9.3 Cell and Tissue Banking Applications
10 Global Stem Cell Manufacturing Market – By End User
10.1 Hospitals and Surgical Centers
10.2 Pharmaceutical and Biotech Companies
10.3 Cell Banks and Tissue Banks
10.4 Academic Institutes, Research Laboratories, and CROs
10.5 Others
11 Global Stem Cell Manufacturing Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Stem Cell Manufacturing Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Stem Cell Manufacturing Market -Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Anterogen
13.3 Becton, Dickinson and Company (BD)
13.4 Merck Group
13.5 Miltenyi Biotec
13.6 Osiris Therapeutics
13.7 Bio-Rad Laboratories
13.8 Holostem Terapie Avanzate
13.9 Lonza Group
13.10 MEDIPOST
13.11 Cellular Dynamics International
13.12 Company 11 & more
14 Global Stem Cell Manufacturing Market – Appendix
14.1 Sources
14.2 Abbreviations
